ARCHIVES

Drug Effectiveness Weakens After Three Years, Study Says

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

May 30, 2014